These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21297105)
1. Development of an HTS-compatible assay for discovery of RORα modulators using AlphaScreen® technology. Istrate MA; Spicer TP; Wang Y; Bernard JA; Helvering LM; Bocchinfuso WP; Richardson TI; Zink R; Kumar N; Montrose-Rafizadeh C; Dodge J; Hodder P; Griffin PR J Biomol Screen; 2011 Feb; 16(2):183-91. PubMed ID: 21297105 [TBL] [Abstract][Full Text] [Related]
2. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758 [TBL] [Abstract][Full Text] [Related]
3. Orphan Nuclear Receptor RORα Regulates Enzymatic Metabolism of Cerebral 24S-Hydroxycholesterol through CYP39A1 Intronic Response Element Activation. Matsuoka H; Katayama M; Ohishi A; Miya K; Tokunaga R; Kobayashi S; Nishimoto Y; Hirooka K; Shima A; Michihara A Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392803 [TBL] [Abstract][Full Text] [Related]
4. Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology. Sturchler E; Chen W; Spicer T; Hodder P; McDonald P; Duckett D Assay Drug Dev Technol; 2014 May; 12(4):229-37. PubMed ID: 24831789 [TBL] [Abstract][Full Text] [Related]
6. Development of an HTS-Compatible Assay for the Discovery of Ulk1 Inhibitors. Rosenberg LH; Lafitte M; Grant W; Chen W; Cleveland JL; Duckett DR J Biomol Screen; 2015 Aug; 20(7):913-20. PubMed ID: 25851035 [TBL] [Abstract][Full Text] [Related]